Physician profile
Jenna E Tarter
NPI 1548777014
$2,470.33
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $453 · 2022: $888 · 2023: $911 · 2024: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $800.66 | 2021-2024 | |
| Novo Nordisk INC | $316.33 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $301.84 | 2021-2023 | Mounjaro, Trulicity, Emgality |
| Supernus Pharmaceuticals, INC. | $148.54 | 2021-2023 | Qelbree |
| Ironshore Pharmaceuticals INC. | $139.86 | 2021-2023 | Jornay Pm |
| Biohaven Pharmaceutical Holding Company LTD. | $135.44 | 2022 | |
| Corium, LLC | $102.01 | 2021-2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $88.15 | 2021-2023 | Flumist Quadrivalent |
| Pfizer INC. | $63.60 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.47 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $56.98 | 2021-2022 | |
| Cranial Technologies, INC | $42.79 | 2022-2023 | Doc Band |
| Kyowa Kirin, INC. | $27.51 | 2023 | Crysvita |
| Teva Pharmaceuticals USA, INC. | $24.06 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.96 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $20.29 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.57 | 2022 | |
| Abbott Laboratories | $19.26 | 2022 | |
| Xeris Pharmaceuticals, INC. | $18.38 | 2024 | Gvoke Hypopen |
| Tris Pharma INC | $15.96 | 2021 | |
| Amgen INC. | $13.49 | 2023 | Repatha |
| Medtronic, INC. | $12.64 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.14 | 2021 | |
| Glaxosmithkline, LLC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Tarter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.